CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...

CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...

Novel combination of acimtamig and an allogenic natural killer cell product shows safety and promising objective response ...

A $50 million gift to Children's Hospital of Philadelphia (CHOP) and Penn Medicine will create an ambitious joint initiative called the Lurie Autism Institute to drive discoveries with transformative ...

ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Immuneel Therapeutics has been awarded a $150,000 G-Rex® Grant to support ...

Quell and AstraZeneca entered a collaboration, exclusive option and license agreement in June 2023 to develop, manufacture and commercialize autologous, engineered Treg cell therapies for two ...

During a live event, Samuel M. Rubinstein, MD, discussed the outcomes from the KarMMa-3 trial and real-world patients ...

A new immunotherapy for treating stomach cancer is helping people live 40% longer. However, some are affected by this ...

Glioblastoma has been deadly and hard to treat, but researchers say they’ve made progress with bivalent CAR T-cell therapy ...

MUSC research to use he immune system to fight cancer shows it can be done safer, cheaper and better. An SC company pushing ...